SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-20-084224
Filing Date
2020-07-16
Accepted
2020-07-16 20:51:54
Documents
1
Period of Report
2020-07-16

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2025045-1_form3.html 3  
1 OWNERSHIP DOCUMENT tm2025045-1_form3.xml 3 6901
  Complete submission text file 0001104659-20-084224.txt   9380
Mailing Address 200 BERKELEY STREET, 18TH FLOOR BOSTON MA 02116
Business Address 200 BERKELEY STREET, 18TH FLOOR BOSTON MA 02116 617-778-2500
RA CAPITAL MANAGEMENT, L.P. (Reporting) CIK: 0001346824 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-39381 | Film No.: 201032596

Mailing Address 200 BERKELEY STREET 18TH FLOOR BOSTON MA 02116
Business Address
Kolchinsky Peter (Reporting) CIK: 0001384859 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39381 | Film No.: 201032597

Mailing Address 200 BERKELEY STREET 18TH FLOOR BOSTON MA 02116
Business Address
Shah Rajeev M. (Reporting) CIK: 0001619841 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39381 | Film No.: 201032598

Mailing Address 134 COOLIDGE AVENUE 2ND FLOOR WATERTOWN MA 02472
Business Address 134 COOLIDGE AVENUE 2ND FLOOR WATERTOWN MA 02472 617-393-5925
Pandion Therapeutics, Inc. (Issuer) CIK: 0001807901 (see all company filings)

IRS No.: 833015614 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations